Author:
Li Congxin,Yan Wei,Gao Meiling,Zhang Zhihan,Zhao Ling,Ma Jingtao,Li Xuejing,Gao Yuan,Zhang Dongxia,Gao Shan
Funder
National Natural Science Foundation of China
Natural Science Foundation of Hebei Province
Research Foundation of Education Bureau of Hebei Province
Hospital Pharmacy Project of Hebei Pharmaceutical Association
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Saleh, Y., Abdelkarim, O., Herzallah, K. & Abela, G. S. Anthracycline-induced cardiotoxicity: Mechanisms of action, incidence, risk factors, prevention, and treatment. Heart Fail. Rev. 26, 1159–1173 (2021).
2. Floyd, J. D. et al. Cardiotoxicity of cancer therapy. J. Clin. Oncol. 23, 7685–7696 (2005).
3. Florescu, M., Cinteza, M. & Vinereanu, D. Chemotherapy-induced Cardiotoxicity. Maedica (Bucur) 8, 59–67 (2013).
4. Han, X., Zhou, Y. & Liu, W. Precision cardio-oncology: Understanding the cardiotoxicity of cancer therapy. NPJ Precis. Oncol. 1, 31 (2017).
5. Albini, A. et al. Cardiotoxicity of anticancer drugs: The need for cardio-oncology and cardio-oncological prevention. J. Natl. Cancer Inst. 102, 14–25 (2010).